Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Month of Birth Does Not Seem to Interfere with the Development of Multiple Sclerosis Later in Life in Brazilian Patients.
Naltrexone
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
Novartis gains FDA approval for Gilenya(TM), a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
Autoimmunity: Rubbing salt in the wound.
Glycerol rhizotomy and radiofrequency thermocoagulation for trigeminal neuralgia in multiple sclerosis.
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning.
Gap junction pathology in multiple sclerosis lesions and normal-appearing white matter.
Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells.
Efficacy of vision restoration therapy after optic neuritis (VISION study): study protocol for a randomized controlled trial.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Immunology: A tolerant approach.
Immune reconstitution inflammatory syndrome mimicking progressive multifocal leucoencephalopathy in a multiple sclerosis patient treated with natalizumab: a case report and review of the literature.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS.
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Biochemical Markers of Autoimmune Diseases of the Nervous System.
[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].
Multiple sclerosis relapses and depression.
Multiple sclerosis disease-modifying therapy prescribing patterns in ontario.
Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.

Pages